Prokopieva Valentina1, Yarygina Ekaterina1, Bokhan Nikolay1, Plotnikov Evgenii1. 1. Valentina (Sc.D), Ekaterina (Ph.D.), Nikolay (Prof.), Mental Health Research Institute, Tomsk National Research Medical Center (TNRMC), Russian Academy of Sciences, Russia. Plotnikov Evgenii, Ph.D., Mental Health Research Institute, Tomsk National Research Medical Center (TNRMC), Russian Academy of Sciences, Russia, and National Research Tomsk Polytechnic University, Tomsk, Russia.
Abstract
Objective: An important step in the development of new drugs for the treatment of bipolar disorder (BD) is the study of the extent to which novel lithium salts whose anionic component has an antioxidant effect can reduce oxidative DNA damage in human blood plasma in vitro. We investigated the effects of lithium salts containing different organic anionic components (lithium carbonate (Li-CAR), pyruvate (Li-PYR), succinate (Li-SUC), fumarate (Li-FUM) and ascorbate (Li-ASC)) on levels of the oxidative damage product of DNA-8-hydroxy-2'-deoxyguanosine (8-OH-dG) in blood plasma after incubation of blood samples from healthy individuals (healthy group) and patients with bipolar disorder (BD-group) with these chemical compounds. Methods: Blood incubation was carried out in the presence of lithium salts (1.2 mM) for 1 hour at 37°C. Measurement of 8-OH-dG concentrations in blood plasma was carried out by enzyme immunoassay using a DNA Damage Competitive Elisa Kit (Thermo Fisher Scientific, USA). Results: In samples without compounds (control), concentrations of 8-OH-dG in the BD-group did not differ from the group of healthy individuals. None of the tested compounds had a significant effect on 8-OH-dG in healthy individuals. In BD patients, Li-PYR significantly reduced levels of plasma 8-OH-dG, while other compounds did not have a noticeable effect. Conclusion: Lithium pyruvate reduces oxidative DNA damage in the blood of BD patients in vitro, demonstrating the potential of this compound to function not only as a mood stabilizer, but also as an antioxidant and cytoprotector.
Objective: An important step in the development of new drugs for the treatment of bipolar disorder (BD) is the study of the extent to which novel lithium salts whose anionic component has an antioxidant effect can reduce oxidative DNA damage in human blood plasma in vitro. We investigated the effects of lithium salts containing different organic anionic components (lithium carbonate (Li-CAR), pyruvate (Li-PYR), succinate (Li-SUC), fumarate (Li-FUM) and ascorbate (Li-ASC)) on levels of the oxidative damage product of DNA-8-hydroxy-2'-deoxyguanosine (8-OH-dG) in blood plasma after incubation of blood samples from healthy individuals (healthy group) and patients with bipolar disorder (BD-group) with these chemical compounds. Methods: Blood incubation was carried out in the presence of lithium salts (1.2 mM) for 1 hour at 37°C. Measurement of 8-OH-dG concentrations in blood plasma was carried out by enzyme immunoassay using a DNA Damage Competitive Elisa Kit (Thermo Fisher Scientific, USA). Results: In samples without compounds (control), concentrations of 8-OH-dG in the BD-group did not differ from the group of healthy individuals. None of the tested compounds had a significant effect on 8-OH-dG in healthy individuals. In BD patients, Li-PYR significantly reduced levels of plasma 8-OH-dG, while other compounds did not have a noticeable effect. Conclusion: Lithium pyruvate reduces oxidative DNA damage in the blood of BD patients in vitro, demonstrating the potential of this compound to function not only as a mood stabilizer, but also as an antioxidant and cytoprotector.
Authors: Frances Bosetti; J Rintala; R Seemann; T A Rosenberger; M A Contreras; S I Rapoport; M C Chang Journal: Mol Psychiatry Date: 2002 Impact factor: 15.992
Authors: Márcio Gerhardt Soeiro-de-Souza; Ana C Andreazza; Andre F Carvalho; Rodrigo Machado-Vieira; L Trevor Young; Ricardo Alberto Moreno Journal: Int J Neuropsychopharmacol Date: 2013-03-01 Impact factor: 5.176
Authors: Mireille Basselin; Nelly E Villacreses; Ho-Joo Lee; Jane M Bell; Stanley I Rapoport Journal: J Neurochem Date: 2007-05-04 Impact factor: 5.372
Authors: Leonardo Tondo; Martin Alda; Michael Bauer; Veerle Bergink; Paul Grof; Tomas Hajek; Ute Lewitka; Rasmus W Licht; Mirko Manchia; Bruno Müller-Oerlinghausen; René E Nielsen; Marylou Selo; Christian Simhandl; Ross J Baldessarini Journal: Int J Bipolar Disord Date: 2019-07-22